Cargando…
Rituximab therapy for juvenile-onset systemic lupus erythematosus
Rituximab (RTX), an anti-CD20 monoclonal antibody, has been proposed for use in the therapy of systemic lupus erythematosus (SLE). We present the initial long-term experience of the safety and efficacy of rituximab for treatment of SLE in children. Eighteen patients (mean age 14 ± 3 years) with seve...
Autores principales: | Nwobi, Obioma, Abitbol, Carolyn L., Chandar, Jayanthi, Seeherunvong, Wacharee, Zilleruelo, Gastón |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Springer-Verlag
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2214826/ https://www.ncbi.nlm.nih.gov/pubmed/18097688 http://dx.doi.org/10.1007/s00467-007-0694-9 |
Ejemplares similares
-
Forty-four-hour interdialytic ambulatory blood pressure monitoring and cardiovascular risk in pediatric hemodialysis patients
por: Katsoufis, Chryso P., et al.
Publicado: (2014) -
Predictors of advanced chronic kidney disease in infancy after definitive vesicoamniotic shunting for congenital lower urinary tract obstruction
por: Katsoufis, Chryso Pefkaros, et al.
Publicado: (2022) -
Spectrum of Clinical Manifestations in Children With WT1 Mutation: Case Series and Literature Review
por: Arroyo-Parejo Drayer, Patricia, et al.
Publicado: (2022) -
Capillary rarefaction: an early marker of microvascular disease in young hemodialysis patients
por: Edwards-Richards, Alcia, et al.
Publicado: (2014) -
Risk Assessment of Severe Congenital Anomalies of the Kidney and Urinary Tract (CAKUT): A Birth Cohort
por: Katsoufis, Chryso P., et al.
Publicado: (2019)